Zobrazeno 1 - 10
of 408
pro vyhledávání: '"I. Pérez Martínez"'
Autor:
D Muiño, L Carballo-Folgoso, J Ortega-Carriedo, P Flórez-Díez, R de Francisco, I Pérez-Martínez, A Castaño-García, E Fernández-González, C García-Pérez, S Martínez-González, V Rolle, S Riestra
Publikováno v:
Journal of Crohn's and Colitis. 17:i303-i305
Background Immune-mediated inflammatory diseases (IMIDs) involve an increased risk of developing atherosclerotic cardiovascular disease (ASCVD). However, the association between inflammatory bowel disease (IBD) and ASCVD is not well established. Our
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94dc8849190de6d34f49544fa81091f5
https://doi.org/10.1093/ecco-jcc/jjac190.0271
https://doi.org/10.1093/ecco-jcc/jjac190.0271
Autor:
R M De Francisco Garcia, I Pérez-Martínez, A Castaño-García, M Celada-Sendino, E Fernández-González, C García-Pérez, S Martínez-Gozález, V Rolle, R Queiro, S Alonso-Castro, J Santos-Juanes, M Gueimonde, S Riestra
Publikováno v:
Journal of Crohn's and Colitis. 17:i981-i983
Background The association of several immune-mediated inflammatory diseases (IMIDs) in the same patient is well known. IMID, especially joint and cutaneous diseases, are frequently diagnosed in patients with inflammatory bowel disease (IBD). However,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a88bfb31ad791ebb06308158bbb731eb
https://doi.org/10.1093/ecco-jcc/jjac190.0989
https://doi.org/10.1093/ecco-jcc/jjac190.0989
Autor:
M Chaparro, M García Donday, S Rubio, C Calviño Suarez, A Nuñez Ortiz, M Figueira, S Marín Pedrosa, M Rivero, A Fernández-Clotet, L Madero, M T Diz-Lois Palomares, I Pérez-Martínez, A Ruiz-Cerulla, M Arroyo, M Piqueras, C Suarez Ferrer, M Aguas, M Calvo Moya, I Guerra, P López Serrano, J M Vázquez Morón, L Arias García, M J Casanova, J M Huguet, G Valldosera Gomis, B Zúñiga de Mora-Figueroa, R Armesto, P Martínez Montiel, I Rodríguez-Lago, P Sendra Rumbeu, R Camargo Camero, D Hervías Cruz, G Molina Arriero, M Barreiro-de Acosta, D Acosta, Y Brenes, S Hermida, P Parra, A Garre, J P Gisbert
Publikováno v:
Journal of Crohn's and Colitis. 17:i874-i876
Background Biological drugs used for IBD are detected in breast milk at a concentration below 10% of the maternal serum concentration and have therefore been considered as permitted drugs. However, warnings have recently been published regarding vacc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8aab631e9d00c3fa00eb5c2a40c5096a
https://doi.org/10.1093/ecco-jcc/jjac190.0874
https://doi.org/10.1093/ecco-jcc/jjac190.0874
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M Gonzalez Vivo, M Urpí Ferreruela, B Castro Senosiain, I Pérez-Martínez, J Barrio, L Codesido Prado, B Caballol Oliva, V Pedrera Roman, M Piqueras Cano, F Rodríguez Moranta, M J Casanova González, L Ramos, M Iborra, C Tardillo Marin, M Barreiro-de Acosta, R H Lorente Poyatos, B Orts Jorquera, L Bujanda Fernández, Y Zabana, A López-García, S Riestra, P Vega-Villaamil, M Montoro, J P Gisbert, P Nos, G E Rodriguez Gonzalez, M Porto Silva, A Gutiérrez-Casbas, E Domenech, L Márquez
Publikováno v:
Journal of Crohn's and Colitis. 16:i208-i210
Background Patients with inflammatory bowel disease (IBD) are often classified as ulcerative colitis (UC) and Crohn’s disease (CD). However, in some cases this categorization is not possible and these patients are labelled as inflammatory bowel dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94c9ff8e40620b76e38da0b61fc8a3ca
https://doi.org/10.1093/ecco-jcc/jjab232.246
https://doi.org/10.1093/ecco-jcc/jjab232.246
Autor:
M Chaparro, A Gutiérrez, C Calviño-Suárez, J M Huguet, M Calvo, M Aguas, R Camargo Camero, M Á de Jorge Turrión, D Hervías Cruz, P López Serrano, S Marín Pedrosa, P Martínez Montiel, M Rivero, R Vicente Lidón, L Arias García, M Arroyo, L Bujanda, M J Casanova, M Figueiras, A J Lucendo, N Manceñido Marcos, L Márquez, M D Martín-Arranz, M Boscá Watts, Y Ber, P Ramírez de la Piscina Urraca, I Pérez-Martínez, V Robles, A Ruiz-Cerulla, J M Vázquez Morón, L Madero, M Barreiro-de Acosta, M Capilla, I Vera Mendoza, D Acosta, Y Brenes, S Hermida, P Parra, M G Donday, J P Gisbert
Publikováno v:
Journal of Crohn's and Colitis. 16:i491-i493
Background The safety of ustekinumab in pregnant patients with inflammatory bowel disease (IBD) and in their offspring has been barely studied. Aims Primary: To know the risk of serious adverse events (SAEs) in women exposed to ustekinumab during pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::937c68b486a568e6c69c84324094d726
https://doi.org/10.1093/ecco-jcc/jjab232.672
https://doi.org/10.1093/ecco-jcc/jjab232.672
Autor:
I Guerra Marina, L Bujanda, M Mañosa, I Pérez-Martínez, M J Casanova, L de la Peña, M de Benito, M Rivero, P Varela, L Bernal, A C Franco, Y Ber, M Piqueras, C Tardillo, Á Ponferrada, S Olivares, A J Lucendo, P Gilabert, M Sierra Ausín, M Bellart, A Herrarte, M Calafat, R de Francisco, J P Gisbert, J Guardiola, E Domènech, F Bermejo
Publikováno v:
Journal of Crohn's and Colitis. 17:i519-i520
Background An increased risk of lymphoma has been described in patients with Inflammatory Bowel Disease (IBD). The aims of our study were to determine the clinical presentation of lymphoma, previous exposure to immunosuppressive and biologic therapie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c91e018fcc1b2945ee37906b304be03
https://doi.org/10.1093/ecco-jcc/jjac190.0516
https://doi.org/10.1093/ecco-jcc/jjac190.0516
Autor:
M Calafat Sard, C Súria, F Mesonero, R de Francisco, C Yagüe Caballero, L de la Peña, A Hernández-Camba, A Marcè, B Gallego, N Martín-Vicente, M Rivero, M Iborra, I Guerra, M Carrillo-Palau, L Madero, B Burgueño, D Montfort, G Torres, M Teller, J Á Ferrer Rosique, P Vega Villaamil, C Roig, Á Ponferrada, E Betoré Glaría, Y Zabana, J P Gisbert, N Alcaide, B Camps, J Legido, M González Vivo, M M Bosca-Watts, I Pérez-Martínez, D Casas Deza, J Guardiola, L Arranz Hernández, M Navarro, F Gomollon, F Cañete, M Mañosa, E Domènech
Publikováno v:
Journal of Crohn's and Colitis. 17:i80-i81
Background The coexistence of immune-mediated diseases and non-pharmacological immunosuppression states are rare and might determine the natural history of the disease and therapeutic decisions of the physician. IBD guidelines recommend screening for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1fa25fa88a54a0d1895cb02d9d15b54d
https://doi.org/10.1093/ecco-jcc/jjac190.0057
https://doi.org/10.1093/ecco-jcc/jjac190.0057
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.